2024-04-20, Sat.

Top Stories       Business       Culture & Life       Science & Technology       World

Lecture

Notification

 

NEWS > Science & Technology


Xlear Teams Up With Dr. Ferrer BioPharma to Bring a Better User Experience to Nasal Hygiene

Recent Study on Computationally-Guided Intranasal Spray Protocol to Augment Therapeutic Penetration With Implications Shown for Effective Treatments for COVID-19, Rhinitis, and Sinusitis
Date: 2022-05-17

AMERICAN FORK, UTAH-- May 17, 2022 -- Today Xlear announced a new partnership with Dr. Ferrer BioPharma (DFBP), which will make Xlear nasal spray the first nasal hygiene tool to deploy the GentleMist nozzle—the next generation nasal spray technology that research shows achieves better compound dispersion and coverage and a better user experience.

Nasal cleansing studies have found that rinsing the nose and nasal cavity is an important tool for improving health and wellbeing. Numerous clinical and lab studies have found that nasal hygiene is an important adjunct in countering rhinositus, as well as a range of bacterial and viral infections.

New research, published by The European Society of Medicine found that the GentleMist nozzle achieved more uniform and more complete dispersion of nasal sprays into the nose and nasal cavity. The study also found that the new nozzle was gentler and significantly improved the user experience over typical nose spray technologies. You can read the full study by clicking here: Evaluation of Patient Experience for a Computationally-Guided Intranasal Spray Protocol to Augment Therapeutic Penetration: Implications for Effective Treatments for COVID-19, Rhinitis, and Sinusitis | Medical Research Archives (esmed.org) https://esmed.org/MRA/mra/article/view/2774

Traditionally nasal sprays have just had a standard pattern where the spray shoots straight up the airway in the direction it is sprayed. The new nozzle is very gentle and the spray is applied in a vortex/whirlpool pattern. This is extremely important and beneficial for Xlear and their customers as it allows Xlear’s mix (saline, xylitol and grapefruit seed extract) to be applied much more effectively and completely to the nose and nasal cavity.

“For more than twenty years, millions of people have been using and benefiting from our nasal spray and we are extremely excited to make this new technology available to them to improve their user experience. We realize that if washing our nose every morning and evening is uncomfortable, or irritating or hurts in even the slightest way we are not going to have people wash their nose enough to where it will make a difference. If it hurt us every time we washed our hands…or brushed our teeth, we wouldn’t be doing that enough either. Just like washing our hands, taking a shower and brushing our teeth, washing our nose is an added layer of protection to keeping us clean and healthy…and breathing better all day,” said Xlear CEO Nate Jones.

Xlear is not intended to diagnose, treat, cure or prevent any disease.



 to the Top List of News

CADvizor CATIA 3D Integration Release: Transforming Electrical Design Experience with ECAD and MCAD Integration
MRM Health Reports Safety and Positive Efficacy Data in Pouchitis in Phase 2a Clinical Study with MH002
Thales and Intel Enable Advanced Protection for the Google Cloud Ecosystem
Smiths Detection launches cutting edge X-ray Diffraction scanner
Trinseo Introduces Groundbreaking Flame-retardant Plastic Grades Without Using PFAS Additives During Manufacturing Process
Sintavia Announces $25M Expansion in Hollywood, Florida
Laserfiche Reimagines Partner Ecosystem to Empower Solution Providers Worldwide

 

Quectel Introduces Versatile BG95-S5 NTN Satellite Communication Modul...
Neuron Launches Network APIs to Enable Application-Driven QoE On Deman...
Quectel Broadens RedCap Offering With Commercial Availability of RG255...
Galaxy AI Now Supports More Languages with Latest Update
Wasabi Technologies Introduces Wasabi AiR, Pioneering Intelligent Medi...
Adani Green Energy Becomes India¡¯s First to Surpass 10,000 MW Renewab...
Phase 3 Comparative Clinical Study of Prolia and Xgeva (denosumab) Bio...
NetApp Wins Google Cloud Technology Partner of the Year Award for Infr...
VeriSilicon Showcased Its Latest Power-Efficient IP Applications at Em...
Echodyne Showcases MESA Radars at Milipol Asia-Pacific TechX Summit 20...

 

 

60, Gamasanro 27gil, Guro-gu, Seoul, Korea, e-mail: news@newsji.com

Copyright, NEWSJI NETWORK.